Some people with myelofibrosis have no symptoms and might not need treatment right away. Others with more-serious forms may need aggressive treatments right away. Some drugs, such as fedratinib (Inrebic), pacritinib (Vonjo), and ruxolitinib (Jakafi) are approved to treat MF. Medications can ease some MF symptoms like bone pain, enlarged spleen, itching, and night sweats. But they can have some side effects. Various methods are available for myelofibrosis treatment, depending on the patient's symptoms and individual circumstances.
Low-risk myelofibrosis may not necessitate urgent therapy, but high-risk myelofibrosis may necessitate severe treatment, such as bone marrow transplant. Myelofibrosis Treatment for intermediate-risk myelofibrosis is often focused on symptom management.
Read the Complete Article- https://latestcmiblogs.weebly.com/article/myelofibrosis-treatment-a-bone-marrow-transplant-is-the-only-potential-cure-for-myelofibrosis